deltatrials
Completed PHASE1/PHASE2 NCT00309868

Study of Nesiritide in Diastolic Heart Failure.

A Study of the Acute Hemodynamic and Myocardial Effects of Nesiritide in Diastolic Heart Failure.

Sponsor: Massachusetts General Hospital

Conditions Diastolic Heart Failure
Interventions neseritide
Updated 6 times since 2017 Last updated: Mar 24, 2014 Started: Dec 31, 2002 Primary completion: Dec 31, 2003 Completion: Dec 31, 2003

A PHASE1/PHASE2 clinical study on Diastolic Heart Failure, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 6 data snapshots since 2002. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Dec 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Massachusetts General Hospital
  • Scios, Inc.
Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.